ConductScience.org, home

Paper39178229

Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.

Dahal A and 12 others. Proc Natl Acad Sci U S A, 2024. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. Papers, record 39178229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39178229

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
3.99, provisional
iCite
Revised in PubMed
2026-08-18
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dahal AAnkithttps://orcid.org/0009-0005-6792-8203
2Hong YYeonsun
3Mathew JSJocelyn S
4Geber AAdam
5Eckl SSarahhttps://orcid.org/0000-0002-4577-2480
6Renner SStephanie
7Sailer CJCooper Jhttps://orcid.org/0000-0001-8055-588X
8Ryan ATAllison Thttps://orcid.org/0000-0002-5133-8373
9Mir SSanahttps://orcid.org/0009-0002-2073-1276
10Lim KKihonghttps://orcid.org/0000-0001-6665-6422
11Linehan DCDavid C
12Gerber SAScott A
13Kim MMinsoohttps://orcid.org/0000-0002-9566-9385

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeutrophilsMajor topic
Cell DifferentiationMajor topic
Tumor MicroenvironmentMajor topic
Platelet Activating FactorMajor topic
Myeloid-Derived Suppressor CellsMajor topic
Humans
Animals
Mice
Cell Line, Tumor
CD8-Positive T-Lymphocytes
Mice, Inbred C57BL

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Al147362HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)PubMedPubMed
Al102851HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)PubMedPubMed
GM007356HHS | NIH | National Institute of General Medical Sciences (NIGMS)T32GM007356PubMed and NIHNIH RePORTER
HL160723HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)R01HL160723PubMed and NIHNIH RePORTER
R01 HL160723NHLBI NIH HHSUnited StatesR01HL160723PubMed and NIHNIH RePORTER
T32 GM007356NIGMS NIH HHSUnited StatesT32GM007356PubMed and NIHNIH RePORTER
P01AI102851NIHNIH RePORTER
R01AI147362NIHNIH RePORTER

Download CSV of grants

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130191175PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo.Sci Adv2018https://conductscience.org/library/papers/30191175PubMed
235675777PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment.Cell Rep2022https://conductscience.org/library/papers/35675777PubMed
335190529Blocking iASPP/Nrf2/M-CSF axis improves anti-cancer effect of chemotherapy-induced senescence by attenuating M2 polarization.Cell Death Dis2022https://conductscience.org/library/papers/35190529PubMed
47807024Inhibition of tumor growth by elimination of granulocytes.J Exp Med1995https://conductscience.org/library/papers/7807024PubMed
514115699A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE.Cancer Res1964https://conductscience.org/library/papers/14115699PubMed
633077737Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.Signal Transduct Target Ther2020https://conductscience.org/library/papers/33077737PubMed
729348500Myeloid-derived suppressor cells coming of age.Nat Immunol2018https://conductscience.org/library/papers/29348500PubMed
815313928Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.Cancer Res2004https://conductscience.org/library/papers/15313928PubMed
934520398Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment.J Clin Invest2021https://conductscience.org/library/papers/34520398PubMed
1021541282A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue.PLoS One2011https://conductscience.org/library/papers/21541282PubMed
1122542595The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.Carcinogenesis2012https://conductscience.org/library/papers/22542595PubMed
1227265504CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Cancer Cell2016https://conductscience.org/library/papers/27265504PubMed
13120307[Origin and biological role of lipid mediators during inflammation (author's transl)].Immun Infekt1979https://conductscience.org/library/papers/120307PubMed
1439178229Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/39178229PubMed
1529445756Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor.J Immunol Res2017https://conductscience.org/library/papers/29445756PubMed
1634439836Neutrophil in the Pancreatic Tumor Microenvironment.Biomolecules2021https://conductscience.org/library/papers/34439836PubMed
1738207030Deterministic reprogramming of neutrophils within tumors.Science2024https://conductscience.org/library/papers/38207030PubMed
1816365420Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression.J Immunol2006https://conductscience.org/library/papers/16365420PubMed
1911309334Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.Clin Cancer Res2001https://conductscience.org/library/papers/11309334PubMed
2037139414The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy.Acta Pharm Sin B2023https://conductscience.org/library/papers/37139414PubMed

See all 56 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42877588Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy.Front Immunol2026https://conductscience.org/library/papers/42877588PubMed
42724439Association between the systemic immune-inflammation index and overall survival in patients with leukemia: a multicenter cohort study.Transl Cancer Res2026https://conductscience.org/library/papers/42724439PubMed
42249048Human immunosuppressive neutrophils: recent answers to old and new questions.EMBO J2026https://conductscience.org/library/papers/42249048PubMed
42082461Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42082461PubMed
41996628Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer-Associated Fibroblasts.Cancer Res Commun2026https://conductscience.org/library/papers/41996628PubMed
41980018Neonatal platelets differentiate monocytes to a myeloid-derived suppressor cell phenotype.Blood2026https://conductscience.org/library/papers/41980018PubMed
41946907Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment.Cell Mol Immunol2026https://conductscience.org/library/papers/41946907PubMed
41923521Ginkgolide B Alleviates Airway Inflammation in Hyperoxia Lung Injury.Immun Inflamm Dis2026https://conductscience.org/library/papers/41923521PubMed
41899581Overcoming MDSC-Mediated Immunosuppression in Hepatocellular Carcinoma: From Mechanisms to Novel Immunotherapeutic Approaches.Cancers (Basel)2026https://conductscience.org/library/papers/41899581PubMed
41686262CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer.Cancer Immunol Res2026https://conductscience.org/library/papers/41686262PubMed
41673656The unseen architects of metastasis: coagulation factors in pre-metastatic niche development.Cell Commun Signal2026https://conductscience.org/library/papers/41673656PubMed
41451221Mechanistic roles of neutrophil heterogeneity in tumour pathogenesis.Front Immunol2025https://conductscience.org/library/papers/41451221PubMed
41430564Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer.Mol Med2025https://conductscience.org/library/papers/41430564PubMed
41368640Mast cell metabolism in cancer: an underexplored frontier demanding more attention.Front Immunol2025https://conductscience.org/library/papers/41368640PubMed
40868150Lipid Metabolism Reprogramming in Cancer: Insights into Tumor Cells and Immune Cells Within the Tumor Microenvironment.Biomedicines2025https://conductscience.org/library/papers/40868150PubMed
40777001Immunotherapy enhances the risk of tumor oxidative stress and metastasis in lung cancer with radiation pneumonitis.Front Immunol2025https://conductscience.org/library/papers/40777001PubMed
40487761Modulation of lipid metabolism by exercise: exploring its potential as a therapeutic target in cancer endocrinology.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40487761PubMed
40214425Platelet-Activating Factor-Induced Inflammation in Obesity: A Two-Sided Coin of Protection and Risk.Cells2025https://conductscience.org/library/papers/40214425PubMed
40148954The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities.Cell Commun Signal2025https://conductscience.org/library/papers/40148954PubMed
39863828Arginine metabolism in myeloid cells in health and disease.Semin Immunopathol2025https://conductscience.org/library/papers/39863828PubMed

See all 21 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LPCAT254947PubTator's text mininghttps://conductscience.org/library/genes/54947NCBI Gene
PCLAF9768PubTator's text mininghttps://conductscience.org/library/genes/9768NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39178229

GET https://conductscience.org/api/papers/v1/39178229/references?page=2